/Investor DB

Polaris Partners — 2021 Investments

11 investments dated 2021 · listed companies and verified rows first · show all

Glympse Bioglympsebio.comDec 2021AcquiredSEC filingmedium confidence

Cambridge, MA biotechnology company developing injectable synthetic biomarkers for noninvasive disease staging and treatment monitoring.

BiotechCambridge, US

Gabriel Kwong(Executive Officer)inSangeeta BhatiainRoopom Banerjee(Executive Officer)in

BoardTheresia Gouw(Director)inStan Lapidus(Director)in

Board seatAmy Schulman· per SEC Form D · $18M raise · filed Dec 2021

Co-investorsGreatPoint VenturesAcrew CapitalARCH Venture PartnersAspect VenturesCatalio Capital ManagementCRV (Charles River Ventures)+7 more

Tectonic Therapeutictectonictx.cominSeries A · Apr 2021 · $80M

Tectonic is a clinical-stage biotechnology company developing therapeutic proteins and antibodies that target G-Protein Coupled Receptors (GPCRs) using a proprietary platform called GEODe™.

AI & Machine LearningBiotechMedical DevicesWatertown, US

Timothy A. Springer(Co-Founder)Andrew C. Kruse(Director)Alise Reicin(Executive Officer, Director)inDaniel Lochner(Executive Officer)Marc Schwabish(Executive Officer)inPeter McNamara(Executive Officer)in

Board seatTerry McGuire· per SEC Form D

Co-investorsEcoR1 CapitalVida VenturesAlly Bridge GroupClarus VenturesFarallon EquitiesSoleus Capital

Armorbloxarmorblox.com𝕏Series B · Feb 2021 · $30Macquired by Cisco

Armorblox provides email security services, including customer support for handling security issues for its business customers.

CybersecurityEnterprise SoftwareSaaS

Anand Raghavan(Founder)Arjun Sambamoorthy(Founder)Chetan Anand(Founder)Dhananjay Sampath(Founder)

Co-investorsMango CapitalNext47Point72 VenturesS VenturesTau VenturesA.Capital Ventures+3 more

August Bioservicesaugustbio.cominSeries A · May 2021 · $24M

August Bioservices is a contract research, development, and manufacturing organization (CDMO) specializing in sterile injectables, offering end-to-end services from development to commercial manufacturing.

Advanced ManufacturingBiotechHealthtechMedical DevicesNew Brunswick, US

Jenn Adams(CEO)

Co-investorsOak HC/FT

Cohere Healthcoherehealth.cominSeries B · Apr 2021 · $36M

Cohere Health provides a platform aimed at aligning the interests of patients, physicians, and health plans to support care decisions and improve member outcomes.

AI & Machine LearningDigital HealthEnterprise SoftwareHealthtechSaaSBoston, US

Siva Namasivayam(Executive Officer, Director)inRobert Shepardson(Executive Officer)inKristen Carucci(Executive Officer)inDuncan Reese(Executive Officer)

BoardDavid Barrett(Director)Amir Debourou(Director)

Co-investorsCota CapitalFlare Capital PartnersLongitude CapitalDeerfield Management CompanyDefine VenturesTemasek

Engine Bioenginebio.comSeries A · May 2021 · $43M

Engine Bio presents itself as a company working on new cancer medicines.

BiotechSingapore, SG

Daphne Teo(Founder)in

Co-investorsClavystBioNSG VenturesWI Harper Group

Kojin TherapeuticsinSeries A · Jun 2021 · $60M

BiotechBoston, US

Nagesh Mahanthappa, Ph.D.(Director)Luba Greenwood(Director)in

BoardAmir Nashat, Ph.D.(Treasurer and Secretary)Susan Langer(President)Thomas J. Cahill(Director)

Co-investors5AM VenturesCathay HealthNewpath Partners

LIVARAlivarahealth.comSeries A · Feb 2021 · $12M

Livara Health provides personalized musculoskeletal (MSK) care through a network of clinicians, using customized care plans to reduce MSK-related costs and improve patient outcomes.

Digital HealthHealthtech

Co-investorsA1 Health VenturesMartin Ventures

Tausighttausight.cominSeries A · Mar 2021 · $20M

Tausight provides Active Containment technology that stops ransomware attacks in real-time by monitoring encryption and preventing operational disruption, eliminating downtime during attacks.

Cybersecurity

David Ting(Founder)in

Co-investorsFlare Capital Partners.406 Ventures

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Blue Rabbit VenturesAnkyra

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.